51. 全身性強皮症 Scleroderma Clinical trials / Disease details


臨床試験数 : 525 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04966416
(ClinicalTrials.gov)
August 1, 202114/7/2021Calcinosis Reduction by Pyrophosphate in SSCThe Effect of Orally Administered Pyrophosphate on Calcinosis Formation in Systematic SclerosisSystemic Sclerosis;SclerodermaDietary Supplement: Pyrophosphate;Dietary Supplement: PlaceboSzeged UniversityResearch Centre for Natural Sciences;University of Debrecen Dept. of RheumatologyNot yet recruiting18 Years70 YearsAll60N/ANULL